Treace Medical Concepts, Inc. Amortization of Debt Discount (Premium)
Treace Medical Concepts, Inc. (TMCI) reported Amortization of Debt Discount (Premium) of $300.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2025-02-27
- Treace Medical Concepts, Inc. amortization of debt discount (premium) for fiscal 2024 was $300.00K, a 0.00% change from fiscal 2023.
- Treace Medical Concepts, Inc. amortization of debt discount (premium) for fiscal 2023 was $300.00K, a 50.00% increase from fiscal 2022.
- Treace Medical Concepts, Inc. amortization of debt discount (premium) for fiscal 2022 was $200.00K, a 0.00% change from fiscal 2021.
- Treace Medical Concepts, Inc. amortization of debt discount (premium) for fiscal 2021 was $200.00K, a 100.00% increase from fiscal 2020.
| Period end | Amortization of Debt Discount (Premium) 12 month |
|---|---|
| 2024-12-31 | $300.00K 10-K · filed 2025-02-27 |
| 2023-12-31 | $300.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | $200.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | $200.00K 10-K · filed 2024-02-27 |
| 2020-12-31 | $100.00K 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |